Opportunistic Play on C&O Pharmaceutical                                                                                 28 Jan 11 Before I start, I will like to emphasis that this short write up is to highlight a possible opportunistic (technical) play on C&O Pharmaceutical (“C&O”) with a horizon of 1-2 weeks (max) and not an in depth analysis on its fundamentals. In addition, I reiterate that this write-up is a general one and does not take into account of the reader’s risk profile. It may or may not be suitable to you. 7.2% YTD drop, 2nd worst performer Among the companies listed in Table 1 below, C&O is the 2nd worst performer, […]